Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2008
05/08/2008WO2008054892A2 Chitin micro-particles as an adjuvant
05/08/2008WO2008054857A1 Process for the preparation of intermediates useful in the treatment of hiv infection
05/08/2008WO2008054808A2 Elvucitabine pharmaceutical compositions
05/08/2008WO2008054796A2 Triazolopyrimidine derivatives as adp p2y12 receptor antagonists
05/08/2008WO2008054795A2 Triazolopyrimidine derivatives as adp p2y12 receptor antagonists
05/08/2008WO2008054767A2 N4 modifications of pyrimidine analogs and uses thereof
05/08/2008WO2008054749A1 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
05/08/2008WO2008054702A1 Anilinopiperazine derivatives and methods of use thereof
05/08/2008WO2008054701A1 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
05/08/2008WO2008054695A2 Composition and method for etiological treatment and prevention of diseases and/or complications associated with chronic glucose metabolism destabilization
05/08/2008WO2008054690A2 Polymorphs of a hydroisoindoline tachykinin receptor antagonist
05/08/2008WO2008054675A2 Antidiabetic bicyclic compounds
05/08/2008WO2008054674A2 Antidiabetic bicyclic compounds
05/08/2008WO2008054639A2 Use of a catechin or polyphenol to treat ocular diseases and infection
05/08/2008WO2008054633A1 Hydrazone derivatives as kinase inhibitors
05/08/2008WO2008054605A2 Non-nucleoside reverse transcriptase inhibitors
05/08/2008WO2008054599A2 Rho kinase inhibitors
05/08/2008WO2008054594A2 Method for controlling angiogenesis in animals
05/08/2008WO2008054540A2 Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
05/08/2008WO2008054475A2 Neuraminidase inhibitors and uses thereof
05/08/2008WO2008054435A2 Use of sk channel activators to prevent relapse/reinstatement of drugs of abuse
05/08/2008WO2008054341A2 Method of bioimaging using nanocrystals of fluorescent dyes
05/08/2008WO2008054293A1 Composition, its use for treating systemic diseases a conditions, and product containing said composition
05/08/2008WO2008054292A1 Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain.
05/08/2008WO2008054291A1 Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain.
05/08/2008WO2008054290A1 1h-pyridine- 2 -one derivatives useful in treatment of pai-1 related disorders
05/08/2008WO2008054288A1 8-sulfonyl-l, 3, 4, 8-tetrahydr0-2h- [1, 4] oxazepino [6, 7-e] indole derivatives and their use as 5-ht6 receptor ligands
05/08/2008WO2008054252A1 Pharmacologically active n,n'-substituted 3,7-diazabicyclo [3.3.1] nonanes, pharmaceutical compositions based thereon and a method for the use thereof
05/08/2008WO2008054188A1 Synergistic pharmaceutical composition comprising lysine clonixinate and carisoprodol
05/08/2008WO2008054123A1 Controlled release complex composition comprising angiotensin-ii-receptor blockers and hmg-coa reductase inhibitors
05/08/2008WO2008054121A1 Controlled release pharmaceutical composition containing thiazides and angiotensin-ii-receptor blockers
05/08/2008WO2008054059A1 Use for treating obesity and diabetes
05/08/2008WO2008053982A1 Composition for treating allergy
05/08/2008WO2008053961A1 Process for production of 1-hydroxy-19-norcyclovitamin d derivative and intermediate for the production
05/08/2008WO2008053920A1 Physiologically active substance-containing granular composition and method of producing the same
05/08/2008WO2008053913A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13
05/08/2008WO2008053909A1 Agent for controlling growth and/or differentiation of mesenchymal stem cell
05/08/2008WO2008053892A1 Pharmaceutical for promoting functional regeneration of damaged tissue
05/08/2008WO2008053863A1 Novel compound having 1,4-benzothiazin-3-one skeleton or 3,4-dihydroquinolin-2-one skeleton
05/08/2008WO2008053861A1 Novel compound having 1,4-benzoxazin-3-one skeleton
05/08/2008WO2008053812A1 Cyanopyridine derivative and medicinal use thereof
05/08/2008WO2008053799A1 W/o/w emulsion composition
05/08/2008WO2008053764A1 Anti-prion active compound, anti-prion active agent, and method for inhibition of the production of abnormal prion protein
05/08/2008WO2008053602A1 5-(1h-1,2,3-triazol-4-yl)-1h-pyrazole derivative
05/08/2008WO2008053517A1 Agent for promoting in vivo dha synthesis and seaweed oil
05/08/2008WO2008053495A1 A novel crystalline form of atorvastatin sodium
05/08/2008WO2008053487A2 Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression
05/08/2008WO2008053446A2 Benzoxazepine compounds, their preparation and use
05/08/2008WO2008053340A1 A combination product comprising at least one lipid substituted in the alpha position and at least one hypoglycemic agent
05/08/2008WO2008053331A1 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar).
05/08/2008WO2008053326A1 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
05/08/2008WO2008053325A1 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
05/08/2008WO2008053319A1 Amide resorcinol compounds
05/08/2008WO2008053301A2 Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
05/08/2008WO2008053300A1 Pyrazoline compounds as mineralocorticoid receptor antagonists
05/08/2008WO2008053297A2 Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa
05/08/2008WO2008053295A2 Pharmaceutical compositions of benzoquinolizine-2-carboxylic acid
05/08/2008WO2008053270A2 Use of an egfr antagonist for the treatment of glomerolonephritis
05/08/2008WO2008053257A1 A pharmaceutical composition having antipsychotic, antidepressant or antiepiieptic activity with reduced side effect
05/08/2008WO2008053256A1 Reduction of overweight or obesity
05/08/2008WO2008053250A2 Formulations for delivery via pressurised metered dose inhalers comprising an essential oil as suspension stabiliser
05/08/2008WO2008053224A1 Treatment of gastrointestinal diseases
05/08/2008WO2008053199A1 Combination therapy for the treatment of respiratory diseases
05/08/2008WO2008053185A1 INHIBITORS OF IKK-β SERINE-THREONINE PROTEIN KINASE
05/08/2008WO2008053182A1 IKK-β SERINE-THREONINE PROTEIN KINASE INHIBITORS
05/08/2008WO2008053158A1 Inhibitors of p38 mitogen-activated protein kinase
05/08/2008WO2008053157A1 Aminoheteroaryl compounds as for the treatment of diseases mediated by c-met kinase activity
05/08/2008WO2008053136A1 2-(hetero-)aryl,4-carbonyl substituted pyrazole derivatives as inhibitors of p38 mitogen-activated protein kinase
05/08/2008WO2008053131A1 Hydroxamates as inhibitors of histone deacetylase
05/08/2008WO2008053031A1 Compounds which potentiate ampa receptor and uses thereof in medicine
05/08/2008WO2008053011A1 Dmae as sole agent for the treatment of mild cognitive impairment
05/08/2008WO2008052974A1 3-amino-pyrazole-4-carboxamide derivatives useful as inhibitors of protein kinases
05/08/2008WO2008052964A1 3-aminocarbonyi-substituted fused pyrazolo-derivatives as protein kinase modulators
05/08/2008WO2008052953A1 The use of pramipexole or a salt thereof for the treatment of parkinson's disease
05/08/2008WO2008052934A1 Novel substituted pyrimidines as cysteine protease inhibitors
05/08/2008WO2008052931A1 A method of administering an antitumor compound
05/08/2008WO2008052912A1 Antimicrobially active composition having a content of bispyridinium alkane (octenidine dihydrochloride)
05/08/2008WO2008052907A1 Substituted 2-imidazoles as modulators of the trace amine associated receptors
05/08/2008WO2008052899A1 Ether derivatives dual modulators of the 5-ht2a and d3 receptors
05/08/2008WO2008052898A1 Indazole derivatives useful as l-cpt1 inhibitors
05/08/2008WO2008052808A1 Cyclic phenyl-substituted indazols, a process for their production and their use as anti-inflammatory agents
05/08/2008WO2008052804A1 Thiazolhydrazides for treatment of neurodegenerative diseases
05/08/2008WO2008052798A2 Fgfr4 promotes cancer cell resistance in response to chemotherapeutic drugs
05/08/2008WO2008052788A1 [f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation
05/08/2008WO2008052769A1 Phenylamino-substituted piperidine compounds, their preparation and use as medicaments
05/08/2008WO2008052734A1 Heterocyclic compounds as antiinflammatory agents
05/08/2008WO2008052733A1 Imidazopyridazines as pi3k lipid kinase inhibitors
05/08/2008WO2008052722A2 Use of ribavirin-conjugates as an anti-viral drug
05/08/2008WO2008052712A1 Solid or aqueous alkaline preparation comprising a creatine component, process for the production thereof and the use thereof
05/08/2008WO2008052671A2 Combination therapy of substituted oxazolidinones
05/08/2008WO2008052658A1 Novel diphenylazetidinone substituted by piperazine-1-sulfonic acid having improved pharmacological properties
05/08/2008WO2008052638A1 DIAZEPANE-ACETAMIDE DERIVATIVES AS SELECTIVE 11β-HSD1 INHIBITORS
05/08/2008WO2008052628A1 Triazabenzo[e]azulene derivatives for the treatment of tumors
05/08/2008WO2008052444A1 Compounds with a six-membered heterocyclic ring, their preparing method and pharmaceutical use
05/08/2008WO2008052441A1 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof
05/08/2008WO2008052432A1 A medicament for improving the semen quality and treating male infertility
05/08/2008WO2008052431A1 Use of composition comprising amlodipine in preparing medicaments for treating a lower urinary tract disorder
05/08/2008WO2008052417A1 Controlled porosity osmotic pump tablet of high permeable drugs and the preparation method thereof
05/08/2008WO2008052410A1 A supermolecule composition of water-soluble coenzyme q10 and preparation method thereof
05/08/2008WO2008052355A1 Method of treating alzheimer's disease
1 ... 3269 3270 3271 3272 3273 3274 3275 3276 3277 3278 3279 3280 3281 3282 3283 3284 3285 3286 3287 3288 3289 ... 7860